{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:10Z","timestamp":1791318310441,"version":"4.3.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,12,21]],"date-time":"2007-12-21T00:00:00Z","timestamp":1198195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1038\/sj.cgt.7701101","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T06:35:30Z","timestamp":1200465330000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Cannabinoid 2 receptor induction by IL-12 and its potential as a therapeutic target for the treatment of anaplastic thyroid carcinoma"],"prefix":"10.1038","volume":"15","author":[{"given":"Y","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Y","family":"Baitei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A S","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R S","family":"Parhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Al-Makhalafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F A","family":"Al-Mohanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,12,21]]},"reference":[{"key":"BF7701101_CR1","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1002\/(SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1","volume":"83","author":"SA Hundahl","year":"1998","unstructured":"Hundahl SA, Fleming ID, Fremgen AM, Menck HR . A National Cancer Data Base report on 53\u2009856 cases of thyroid carcinoma treated in the US 1985\u20131995 [see comments]. Cancer 1998; 83: 2638\u20132648.","journal-title":"Cancer"},{"key":"BF7701101_CR2","first-page":"202","volume":"15","author":"NR Farid","year":"1994","unstructured":"Farid NR, Shi Y, Zou M . Molecular basis of thyroid cancer. Endocr Rev 1994; 15: 202\u2013232.","journal-title":"Endocr Rev"},{"key":"BF7701101_CR3","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1245\/ASO.2006.05.042","volume":"13","author":"C Are","year":"2006","unstructured":"Are C, Shaha AR . Anaplastic thyroid carcinoma: biology, pathogenesis, prognostic factors, and treatment approaches. Ann Surg Oncol 2006; 13: 453\u2013464.","journal-title":"Ann Surg Oncol"},{"key":"BF7701101_CR4","first-page":"175","volume":"29","author":"M Schott","year":"2004","unstructured":"Schott M, Scherbaum WA . Immunotherapy and gene therapy of thyroid cancer. Minerva Endocrinol 2004; 29: 175\u2013187.","journal-title":"Minerva Endocrinol"},{"key":"BF7701101_CR5","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1517\/14712598.4.8.1225","volume":"4","author":"L Barzon","year":"2004","unstructured":"Barzon L, Pacenti M, Boscaro M, Palu G . Gene therapy for thyroid cancer. Expert Opin Biol Ther 2004; 4: 1225\u20131239.","journal-title":"Expert Opin Biol Ther"},{"key":"BF7701101_CR6","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1023\/A:1008304721889","volume":"10","author":"P Nanni","year":"1999","unstructured":"Nanni P, Forni G, Lollini PL . Cytokine gene therapy: hopes and pitfalls. Ann Oncol 1999; 10: 261\u2013266.","journal-title":"Ann Oncol"},{"key":"BF7701101_CR7","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1517\/14712598.4.10.1595","volume":"4","author":"PJ Wysocki","year":"2004","unstructured":"Wysocki PJ, Karczewska-Dzionk A, Mackiewicz-Wysocka M, Mackiewicz A . Human cancer gene therapy with cytokine gene-modified cells. Expert Opin Biol Ther 2004; 4: 1595\u20131607.","journal-title":"Expert Opin Biol Ther"},{"key":"BF7701101_CR8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.2174\/156652305774964712","volume":"5","author":"B Sangro","year":"2005","unstructured":"Sangro B, Melero I, Qian C, Prieto J . Gene therapy of cancer based on interleukin 12. Curr Gene Ther 2005; 5: 573\u2013581.","journal-title":"Curr Gene Ther"},{"key":"BF7701101_CR9","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1089\/104303403322611755","volume":"14","author":"Y Shi","year":"2003","unstructured":"Shi Y, Parhar RS, Zou M, Baitei E, Kessie G, Farid NR et al. Gene therapy of anaplastic thyroid carcinoma with a single-chain interleukin-12 fusion protein. Hum Gene Ther 2003; 14: 1741\u20131751.","journal-title":"Hum Gene Ther"},{"key":"BF7701101_CR10","doi-asserted-by":"publisher","first-page":"6146","DOI":"10.1210\/jc.2004-0418","volume":"89","author":"M Zou","year":"2004","unstructured":"Zou M, Famulski KS, Parhar RS, Baitei E, Al-Mohanna FA, Farid NR et al. Microarray analysis of metastasis-associated gene expression profiling in a murine model of thyroid carcinoma pulmonary metastasis: identification of S100A4 (Mts1) gene overexpression as a poor prognostic marker for thyroid carcinoma. J Clin Endocrinol Metab 2004; 89: 6146\u20136154.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF7701101_CR11","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1210\/jc.2006-0155","volume":"91","author":"Y Shi","year":"2006","unstructured":"Shi Y, Zou M, Collison K, Baitei EY, Al-Makhalafi Z, Farid NR et al. Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model. J Clin Endocrinol Metab 2006; 91: 2373\u20132379.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF7701101_CR12","first-page":"5784","volume":"61","author":"C Sanchez","year":"2001","unstructured":"Sanchez C, de Ceballos ML, del Pulgar TG, Rueda D, Corbacho C, Velasco G et al. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer Res 2001; 61: 5784\u20135789.","journal-title":"Cancer Res"},{"key":"BF7701101_CR13","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1172\/JCI200420303","volume":"113","author":"I Airoldi","year":"2004","unstructured":"Airoldi I, Di Carlo E, Banelli B, Moserle L, Cocco C, Pezzolo A et al. The IL-12Rbeta2 gene functions as a tumor suppressor in human B cell malignancies. J Clin Invest 2004; 113: 1651\u20131659.","journal-title":"J Clin Invest"},{"key":"BF7701101_CR14","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1016\/j.yexcr.2006.03.009","volume":"312","author":"B Herrera","year":"2006","unstructured":"Herrera B, Carracedo A, Diez-Zaera M, Gomez del Pulgar T, Guzman M, Velasco G . The CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathway. Exp Cell Res 2006; 312: 2121\u20132131.","journal-title":"Exp Cell Res"},{"key":"BF7701101_CR15","doi-asserted-by":"publisher","first-page":"5084","DOI":"10.1016\/j.febslet.2005.08.021","volume":"579","author":"B Herrera","year":"2005","unstructured":"Herrera B, Carracedo A, Diez-Zaera M, Guzman M, Velasco G . p38 MAPK is involved in CB2 receptor-induced apoptosis of human leukaemia cells. FEBS Lett 2005; 579: 5084\u20135088.","journal-title":"FEBS Lett"},{"key":"BF7701101_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/sj.onc.1204062","volume":"20","author":"SS Bacus","year":"2001","unstructured":"Bacus SS, Gudkov AV, Lowe M, Lyass L, Yung Y, Komarov AP et al. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53. Oncogene 2001; 20: 147\u2013155.","journal-title":"Oncogene"},{"key":"BF7701101_CR17","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1038\/nrc1188","volume":"3","author":"M Guzman","year":"2003","unstructured":"Guzman M . Cannabinoids: potential anticancer agents. Nat Rev Cancer 2003; 3: 745\u2013755.","journal-title":"Nat Rev Cancer"},{"key":"BF7701101_CR18","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.bjp.0706632","volume":"148","author":"M Bifulco","year":"2006","unstructured":"Bifulco M, Laezza C, Pisanti S, Gazzerro P . Cannabinoids and cancer: pros and cons of an antitumour strategy. Br J Pharmacol 2006; 148: 123\u2013135.","journal-title":"Br J Pharmacol"},{"key":"BF7701101_CR19","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm0602-547","volume":"8","author":"M Bifulco","year":"2002","unstructured":"Bifulco M, Di Marzo V . Targeting the endocannabinoid system in cancer therapy: a call for further research. Nat Med 2002; 8: 547\u2013550.","journal-title":"Nat Med"},{"key":"BF7701101_CR20","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1158\/0008-5472.CAN-03-3927","volume":"64","author":"C Blazquez","year":"2004","unstructured":"Blazquez C, Gonzalez-Feria L, Alvarez L, Haro A, Casanova ML, Guzman M . Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas. Cancer Res 2004; 64: 5617\u20135623.","journal-title":"Cancer Res"},{"key":"BF7701101_CR21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/CCO.0b013e328011ab86","volume":"19","author":"VV Vasko","year":"2007","unstructured":"Vasko VV, Saji M . Molecular mechanisms involved in differentiated thyroid cancer invasion and metastasis. Curr Opin Oncol 2007; 19: 11\u201317.","journal-title":"Curr Opin Oncol"},{"key":"BF7701101_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/erc.1.0978","volume":"12","author":"M Xing","year":"2005","unstructured":"Xing M . BRAF mutation in thyroid cancer. Endocr Relat Cancer 2005; 12: 245\u2013262.","journal-title":"Endocr Relat Cancer"},{"key":"BF7701101_CR23","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1182\/blood-2004-03-1182","volume":"105","author":"T Powles","year":"2005","unstructured":"Powles T, te Poele R, Shamash J, Chaplin T, Propper D, Joel S et al. Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway. Blood 2005; 105: 1214\u20131221.","journal-title":"Blood"},{"key":"BF7701101_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1172\/JCI200316116","volume":"111","author":"ML Casanova","year":"2003","unstructured":"Casanova ML, Blazquez C, Martinez-Palacio J, Villanueva C, Fernandez-Acenero MJ, Huffman JW et al. Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors. J Clin Invest 2003; 111: 43\u201350.","journal-title":"J Clin Invest"},{"key":"BF7701101_CR25","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1158\/0008-5472.CAN-04-3410","volume":"65","author":"S Sarfaraz","year":"2005","unstructured":"Sarfaraz S, Afaq F, Adhami VM, Mukhtar H . Cannabinoid receptor as a novel target for the treatment of prostate cancer. Cancer Res 2005; 65: 1635\u20131641.","journal-title":"Cancer Res"},{"key":"BF7701101_CR26","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1096\/fj.06-6638fje","volume":"20","author":"C Blazquez","year":"2006","unstructured":"Blazquez C, Carracedo A, Barrado L, Real PJ, Fernandez-Luna JL, Velasco G et al. Cannabinoid receptors as novel targets for the treatment of melanoma. FASEB J 2006; 20: 2633\u20132635.","journal-title":"FASEB J"},{"key":"BF7701101_CR27","doi-asserted-by":"publisher","first-page":"6748","DOI":"10.1158\/0008-5472.CAN-06-0169","volume":"66","author":"A Carracedo","year":"2006","unstructured":"Carracedo A, Gironella M, Lorente M, Garcia S, Guzman M, Velasco G et al. Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes. Cancer Res 2006; 66: 6748\u20136755.","journal-title":"Cancer Res"},{"key":"BF7701101_CR28","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1182\/blood-2002-01-0098","volume":"100","author":"RJ McKallip","year":"2002","unstructured":"McKallip RJ, Lombard C, Fisher M, Martin BR, Ryu S, Grant S et al. Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease. Blood 2002; 100: 627\u2013634.","journal-title":"Blood"},{"key":"BF7701101_CR29","doi-asserted-by":"publisher","first-page":"6854","DOI":"10.1074\/jbc.M608900200","volume":"282","author":"T Aguado","year":"2007","unstructured":"Aguado T, Carracedo A, Julien B, Velasco G, Milman G, Mechoulam R et al. Cannabinoids induce glioma stem-like cell differentiation and inhibit gliomagenesis. J Biol Chem 2007; 282: 6854\u20136862.","journal-title":"J Biol Chem"},{"key":"BF7701101_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.cancergencyto.2006.06.014","volume":"171","author":"X Xu","year":"2006","unstructured":"Xu X, Liu Y, Huang S, Liu G, Xie C, Zhou J et al. Overexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinoma. Cancer Genet Cytogenet 2006; 171: 31\u201338.","journal-title":"Cancer Genet Cytogenet"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/7701101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7701101","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/7701101.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T14:15:51Z","timestamp":1647958551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/7701101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,21]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["BF7701101"],"URL":"https:\/\/doi.org\/10.1038\/sj.cgt.7701101","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,21]]},"assertion":[{"value":"28 April 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}